BiotechTube
Tianjin GreenPine Pharma

Tianjin GreenPine Pharma

Tianjin, China· Est.
en.greenpine.com.cn
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

A Chinese pharma company that imports and develops global drugs and medical devices for oncology and cardiovascular markets in China.

OncologyCardiovascular

Technology Platform

The company utilizes a selective licensing and partnership model rather than a proprietary technology platform, focusing on introducing and developing global pharmaceutical products and medical devices for the Chinese market through regulatory and quality research.

Opportunities

Growth opportunities include leveraging China's MAH system to expand its portfolio of licensed international drugs, capitalizing on increasing demand for high-quality imported oncology and cardiovascular therapeutics, and expanding its position in the specialized medical device market for endoscopic surgery.

Risk Factors

Key risks include dependence on foreign manufacturing partners for supply, regulatory delays in product approvals, intense competition in the Chinese pharmaceutical import market, and potential pricing pressures from national procurement policies.

Competitive Landscape

GreenPine competes with other Chinese pharmaceutical importers and distributors, as well as domestic manufacturers. Its differentiation lies in its established network of international cGMP partners, a focus on specific surgical device niches, and an integrated approach covering regulatory, quality, and commercial functions under the MAH system.

More companies in China →